"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"

Completed · Phase 3

Conditions studied: Narcolepsy, Obstructive Sleep Apnea

In brief

This is a Phase 3 study to assess the long-term safety and maintenance of efficacy of JZP-110 in subjects who have completed Study 14-002, 14-003, 14-004, 15-004, 15-005, ADX-N05 201, or ADX-N05 202.

Key facts

Study ID
NCT02348632
Run by
Jazz Pharmaceuticals
People needed
645
Starts
2015-05-01
Expected to finish
2017-12-01
Last updated by the study team
2019-06-25

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.